|
January 12, 2006 Categories: Uncategorized Posted by admin
After more than a year of courtship, Johnson & Johnson has again sweetened its bid for Guidant but rival Boston Scientific Corp. isn’t ceding ground in its quest to acquire the medical device maker.
Guidant Corp.’s board unanimously endorsed a new, $23.2 billion bid from J&J late Wednesday and recommended its shareholders approve it Jan. 31 when they gather to vote. Boston Scientific immediately said it would continue working to advance its own $25 billion offer.
Full news
|
|
